Safety issues related to the use of prescription drugs in patients with chronic diseases: a bibliographic review

Purpose A literature review was conducted with the aim of investigating the impact of treatments associated with an increased risk of hypertension, hyperglycaemia, hyperkalaemia, bone fracture and serotonin syndrome, by taking into account the most prevalent pathologies, the drugs most frequently pr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Drugs & therapy perspectives : for rational drug selection and use 2017-03, Vol.33 (3), p.133-146
Hauptverfasser: Padilla López, Ana, Moreno Fernández, Mª José, Jiménez Heredia, Mercedes, Savall Calabuig, Vicent
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 146
container_issue 3
container_start_page 133
container_title Drugs & therapy perspectives : for rational drug selection and use
container_volume 33
creator Padilla López, Ana
Moreno Fernández, Mª José
Jiménez Heredia, Mercedes
Savall Calabuig, Vicent
description Purpose A literature review was conducted with the aim of investigating the impact of treatments associated with an increased risk of hypertension, hyperglycaemia, hyperkalaemia, bone fracture and serotonin syndrome, by taking into account the most prevalent pathologies, the drugs most frequently prescribed at the outpatient level, as well as the adverse effects they produce. Methods A bibliographical search of scientific publications in MEDLINE, published between 1 January 2006 and 31 December 2015 in English and Spanish, was conducted using 21 keywords. Data, primarily from editorials, non-US government supported research, and reviews, were collected. Other data sources included the websites for the Spanish Agency of Medicines and Medical Devices and the European Medicines Agency, information bulletins on therapeutic information (e.g. the International Society of Drug Bulletins ), other guidelines and reference books. Results From the 24,083 publications identified, 33 articles were selected and their full texts retrieved; 41 articles were included from the references from these articles. Other sources of data were 16 documents from regulatory agencies, seven bulletins, nine guidelines and two books. Approximately 25 therapeutic groups, including nonsteroidal anti-inflammatory drugs, β-blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor antagonists, opioid analgesics, certain antidiabetics, antipsychotics, benzodiazepines and long-term oral corticosteroids, were found to be the most frequently involved in medication-related problems. Conclusions This review has helped identify a set of drugs that should be included in a strategy for ‘high-alert medications’ and in ambulatory care medication revisions for preventing adverse drug reactions, especially the therapeutic groups included in the high-risk drugs list for chronic or geriatric patients and those drugs responsible for emergency visits and hospital admissions.
doi_str_mv 10.1007/s40267-016-0371-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1924515356</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1924515356</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1839-6db29ac2a5657f2fc47f3c9a0aa61bddbccbd66f5280c0c895d1033f12ae64333</originalsourceid><addsrcrecordid>eNp1kEtOwzAQhi0EEqVwAHaWWAf8SJyYHap4SZVYAGvLcezGVUlSj0PV23AWToYhLNiwmpH-x2g-hM4puaSElFeQEybKjFCREV7STB6gGaWlzKgsy8OfnSVFkGN0ArAmhFSC0xnaPmtn4x57gNECDnajo21w7D8_YmvxCBb3Dg_Bggl-iL7vcBPGFWDf4UFHb7sIeOdji00b-s4b3HiwGixcY41rX298vwp6aJMS7Lu3u1N05PQG7NnvnKPXu9uXxUO2fLp_XNwsM0MrLjPR1Exqw3QhitIxZ_LScSM10VrQumlqY-pGCFewihhiKlk0lHDuKNNW5JzzObqYeofQb9NvUa37MXTppKKS5QUteCGSi04uE3qAYJ0agn_TYa8oUd9k1URWJbLqm6ySKcOmDCRvt7LhT_O_oS_qrH5R</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1924515356</pqid></control><display><type>article</type><title>Safety issues related to the use of prescription drugs in patients with chronic diseases: a bibliographic review</title><source>SpringerLink Journals - AutoHoldings</source><creator>Padilla López, Ana ; Moreno Fernández, Mª José ; Jiménez Heredia, Mercedes ; Savall Calabuig, Vicent</creator><creatorcontrib>Padilla López, Ana ; Moreno Fernández, Mª José ; Jiménez Heredia, Mercedes ; Savall Calabuig, Vicent</creatorcontrib><description>Purpose A literature review was conducted with the aim of investigating the impact of treatments associated with an increased risk of hypertension, hyperglycaemia, hyperkalaemia, bone fracture and serotonin syndrome, by taking into account the most prevalent pathologies, the drugs most frequently prescribed at the outpatient level, as well as the adverse effects they produce. Methods A bibliographical search of scientific publications in MEDLINE, published between 1 January 2006 and 31 December 2015 in English and Spanish, was conducted using 21 keywords. Data, primarily from editorials, non-US government supported research, and reviews, were collected. Other data sources included the websites for the Spanish Agency of Medicines and Medical Devices and the European Medicines Agency, information bulletins on therapeutic information (e.g. the International Society of Drug Bulletins ), other guidelines and reference books. Results From the 24,083 publications identified, 33 articles were selected and their full texts retrieved; 41 articles were included from the references from these articles. Other sources of data were 16 documents from regulatory agencies, seven bulletins, nine guidelines and two books. Approximately 25 therapeutic groups, including nonsteroidal anti-inflammatory drugs, β-blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor antagonists, opioid analgesics, certain antidiabetics, antipsychotics, benzodiazepines and long-term oral corticosteroids, were found to be the most frequently involved in medication-related problems. Conclusions This review has helped identify a set of drugs that should be included in a strategy for ‘high-alert medications’ and in ambulatory care medication revisions for preventing adverse drug reactions, especially the therapeutic groups included in the high-risk drugs list for chronic or geriatric patients and those drugs responsible for emergency visits and hospital admissions.</description><identifier>ISSN: 1172-0360</identifier><identifier>EISSN: 1179-1977</identifier><identifier>DOI: 10.1007/s40267-016-0371-9</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Ambulatory care ; Analgesics ; Anticoagulants ; Chronic illnesses ; Editorials ; Enzymes ; Hospitals ; Hyperglycemia ; Hypertension ; Libraries ; Medicine ; Narcotics ; Nonsteroidal anti-inflammatory drugs ; Older people ; Osteoporosis ; Patient admissions ; Pharmacotherapy ; Pharmacy ; Prescription drugs ; Primary care ; Psychotropic drugs ; Review Article ; Serotonin</subject><ispartof>Drugs &amp; therapy perspectives : for rational drug selection and use, 2017-03, Vol.33 (3), p.133-146</ispartof><rights>Springer International Publishing Switzerland 2017</rights><rights>Copyright Springer Science &amp; Business Media Mar 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1839-6db29ac2a5657f2fc47f3c9a0aa61bddbccbd66f5280c0c895d1033f12ae64333</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s40267-016-0371-9$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s40267-016-0371-9$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids></links><search><creatorcontrib>Padilla López, Ana</creatorcontrib><creatorcontrib>Moreno Fernández, Mª José</creatorcontrib><creatorcontrib>Jiménez Heredia, Mercedes</creatorcontrib><creatorcontrib>Savall Calabuig, Vicent</creatorcontrib><title>Safety issues related to the use of prescription drugs in patients with chronic diseases: a bibliographic review</title><title>Drugs &amp; therapy perspectives : for rational drug selection and use</title><addtitle>Drugs Ther Perspect</addtitle><description>Purpose A literature review was conducted with the aim of investigating the impact of treatments associated with an increased risk of hypertension, hyperglycaemia, hyperkalaemia, bone fracture and serotonin syndrome, by taking into account the most prevalent pathologies, the drugs most frequently prescribed at the outpatient level, as well as the adverse effects they produce. Methods A bibliographical search of scientific publications in MEDLINE, published between 1 January 2006 and 31 December 2015 in English and Spanish, was conducted using 21 keywords. Data, primarily from editorials, non-US government supported research, and reviews, were collected. Other data sources included the websites for the Spanish Agency of Medicines and Medical Devices and the European Medicines Agency, information bulletins on therapeutic information (e.g. the International Society of Drug Bulletins ), other guidelines and reference books. Results From the 24,083 publications identified, 33 articles were selected and their full texts retrieved; 41 articles were included from the references from these articles. Other sources of data were 16 documents from regulatory agencies, seven bulletins, nine guidelines and two books. Approximately 25 therapeutic groups, including nonsteroidal anti-inflammatory drugs, β-blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor antagonists, opioid analgesics, certain antidiabetics, antipsychotics, benzodiazepines and long-term oral corticosteroids, were found to be the most frequently involved in medication-related problems. Conclusions This review has helped identify a set of drugs that should be included in a strategy for ‘high-alert medications’ and in ambulatory care medication revisions for preventing adverse drug reactions, especially the therapeutic groups included in the high-risk drugs list for chronic or geriatric patients and those drugs responsible for emergency visits and hospital admissions.</description><subject>Ambulatory care</subject><subject>Analgesics</subject><subject>Anticoagulants</subject><subject>Chronic illnesses</subject><subject>Editorials</subject><subject>Enzymes</subject><subject>Hospitals</subject><subject>Hyperglycemia</subject><subject>Hypertension</subject><subject>Libraries</subject><subject>Medicine</subject><subject>Narcotics</subject><subject>Nonsteroidal anti-inflammatory drugs</subject><subject>Older people</subject><subject>Osteoporosis</subject><subject>Patient admissions</subject><subject>Pharmacotherapy</subject><subject>Pharmacy</subject><subject>Prescription drugs</subject><subject>Primary care</subject><subject>Psychotropic drugs</subject><subject>Review Article</subject><subject>Serotonin</subject><issn>1172-0360</issn><issn>1179-1977</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNp1kEtOwzAQhi0EEqVwAHaWWAf8SJyYHap4SZVYAGvLcezGVUlSj0PV23AWToYhLNiwmpH-x2g-hM4puaSElFeQEybKjFCREV7STB6gGaWlzKgsy8OfnSVFkGN0ArAmhFSC0xnaPmtn4x57gNECDnajo21w7D8_YmvxCBb3Dg_Bggl-iL7vcBPGFWDf4UFHb7sIeOdji00b-s4b3HiwGixcY41rX298vwp6aJMS7Lu3u1N05PQG7NnvnKPXu9uXxUO2fLp_XNwsM0MrLjPR1Exqw3QhitIxZ_LScSM10VrQumlqY-pGCFewihhiKlk0lHDuKNNW5JzzObqYeofQb9NvUa37MXTppKKS5QUteCGSi04uE3qAYJ0agn_TYa8oUd9k1URWJbLqm6ySKcOmDCRvt7LhT_O_oS_qrH5R</recordid><startdate>20170301</startdate><enddate>20170301</enddate><creator>Padilla López, Ana</creator><creator>Moreno Fernández, Mª José</creator><creator>Jiménez Heredia, Mercedes</creator><creator>Savall Calabuig, Vicent</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20170301</creationdate><title>Safety issues related to the use of prescription drugs in patients with chronic diseases: a bibliographic review</title><author>Padilla López, Ana ; Moreno Fernández, Mª José ; Jiménez Heredia, Mercedes ; Savall Calabuig, Vicent</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1839-6db29ac2a5657f2fc47f3c9a0aa61bddbccbd66f5280c0c895d1033f12ae64333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Ambulatory care</topic><topic>Analgesics</topic><topic>Anticoagulants</topic><topic>Chronic illnesses</topic><topic>Editorials</topic><topic>Enzymes</topic><topic>Hospitals</topic><topic>Hyperglycemia</topic><topic>Hypertension</topic><topic>Libraries</topic><topic>Medicine</topic><topic>Narcotics</topic><topic>Nonsteroidal anti-inflammatory drugs</topic><topic>Older people</topic><topic>Osteoporosis</topic><topic>Patient admissions</topic><topic>Pharmacotherapy</topic><topic>Pharmacy</topic><topic>Prescription drugs</topic><topic>Primary care</topic><topic>Psychotropic drugs</topic><topic>Review Article</topic><topic>Serotonin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Padilla López, Ana</creatorcontrib><creatorcontrib>Moreno Fernández, Mª José</creatorcontrib><creatorcontrib>Jiménez Heredia, Mercedes</creatorcontrib><creatorcontrib>Savall Calabuig, Vicent</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Drugs &amp; therapy perspectives : for rational drug selection and use</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Padilla López, Ana</au><au>Moreno Fernández, Mª José</au><au>Jiménez Heredia, Mercedes</au><au>Savall Calabuig, Vicent</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Safety issues related to the use of prescription drugs in patients with chronic diseases: a bibliographic review</atitle><jtitle>Drugs &amp; therapy perspectives : for rational drug selection and use</jtitle><stitle>Drugs Ther Perspect</stitle><date>2017-03-01</date><risdate>2017</risdate><volume>33</volume><issue>3</issue><spage>133</spage><epage>146</epage><pages>133-146</pages><issn>1172-0360</issn><eissn>1179-1977</eissn><abstract>Purpose A literature review was conducted with the aim of investigating the impact of treatments associated with an increased risk of hypertension, hyperglycaemia, hyperkalaemia, bone fracture and serotonin syndrome, by taking into account the most prevalent pathologies, the drugs most frequently prescribed at the outpatient level, as well as the adverse effects they produce. Methods A bibliographical search of scientific publications in MEDLINE, published between 1 January 2006 and 31 December 2015 in English and Spanish, was conducted using 21 keywords. Data, primarily from editorials, non-US government supported research, and reviews, were collected. Other data sources included the websites for the Spanish Agency of Medicines and Medical Devices and the European Medicines Agency, information bulletins on therapeutic information (e.g. the International Society of Drug Bulletins ), other guidelines and reference books. Results From the 24,083 publications identified, 33 articles were selected and their full texts retrieved; 41 articles were included from the references from these articles. Other sources of data were 16 documents from regulatory agencies, seven bulletins, nine guidelines and two books. Approximately 25 therapeutic groups, including nonsteroidal anti-inflammatory drugs, β-blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor antagonists, opioid analgesics, certain antidiabetics, antipsychotics, benzodiazepines and long-term oral corticosteroids, were found to be the most frequently involved in medication-related problems. Conclusions This review has helped identify a set of drugs that should be included in a strategy for ‘high-alert medications’ and in ambulatory care medication revisions for preventing adverse drug reactions, especially the therapeutic groups included in the high-risk drugs list for chronic or geriatric patients and those drugs responsible for emergency visits and hospital admissions.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><doi>10.1007/s40267-016-0371-9</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1172-0360
ispartof Drugs & therapy perspectives : for rational drug selection and use, 2017-03, Vol.33 (3), p.133-146
issn 1172-0360
1179-1977
language eng
recordid cdi_proquest_journals_1924515356
source SpringerLink Journals - AutoHoldings
subjects Ambulatory care
Analgesics
Anticoagulants
Chronic illnesses
Editorials
Enzymes
Hospitals
Hyperglycemia
Hypertension
Libraries
Medicine
Narcotics
Nonsteroidal anti-inflammatory drugs
Older people
Osteoporosis
Patient admissions
Pharmacotherapy
Pharmacy
Prescription drugs
Primary care
Psychotropic drugs
Review Article
Serotonin
title Safety issues related to the use of prescription drugs in patients with chronic diseases: a bibliographic review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T16%3A11%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Safety%20issues%20related%20to%C2%A0the%20use%20of%20prescription%20drugs%20in%20patients%20with%20chronic%20diseases:%20a%20bibliographic%20review&rft.jtitle=Drugs%20&%20therapy%20perspectives%20:%20for%20rational%20drug%20selection%20and%20use&rft.au=Padilla%20L%C3%B3pez,%20Ana&rft.date=2017-03-01&rft.volume=33&rft.issue=3&rft.spage=133&rft.epage=146&rft.pages=133-146&rft.issn=1172-0360&rft.eissn=1179-1977&rft_id=info:doi/10.1007/s40267-016-0371-9&rft_dat=%3Cproquest_cross%3E1924515356%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1924515356&rft_id=info:pmid/&rfr_iscdi=true